These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9748672)

  • 21. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.
    Filippi M; Yousry T; Campi A; Kandziora C; Colombo B; Voltz R; Martinelli V; Spuler S; Bressi S; Scotti G; Comi G
    Neurology; 1996 Feb; 46(2):379-84. PubMed ID: 8614498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evolution of acute "black hole" lesions in patients with relapsing-remitting multiple sclerosis.
    Kostic D; Dincic E; Jovanovski A; Kostic S; Rancic N; Georgievski-Brkic B; Misovic M; Koprivsek K
    Acta Neurol Belg; 2023 Jun; 123(3):831-838. PubMed ID: 35397094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the sensitivity of MRI after double- and triple-dose Gd-DTPA for detecting enhancing lesions in multiple sclerosis.
    Gasperini C; Paolillo A; Rovaris M; Yousry TA; Capra R; Bastianello S; Filippi M
    Magn Reson Imaging; 2000 Jul; 18(6):761-3. PubMed ID: 10930786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
    Taschner CA; Kirsch EC; Scheffler K; Wetzel SG; Schulte-Mönting J; Kappos L; Radü EW
    Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A one year study of new lesions in multiple sclerosis using monthly gadolinium enhanced MRI: correlations with changes of T2 and magnetization transfer lesion loads.
    Filippi M; Rocca MA; Horsfield MA; Comi G
    J Neurol Sci; 1998 Jun; 158(2):203-8. PubMed ID: 9702692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging.
    Mathews VP; Caldemeyer KS; Lowe MJ; Greenspan SL; Weber DM; Ulmer JL
    Radiology; 1999 Apr; 211(1):257-63. PubMed ID: 10189481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain MR post-gadolinium contrast in multiple sclerosis: the role of magnetization transfer and image subtraction in detecting more enhancing lesions.
    Gavra MM; Voumvourakis C; Gouliamos AD; Sfagos C; Vlahos LJ
    Neuroradiology; 2004 Mar; 46(3):205-10. PubMed ID: 14985887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.
    Martinelli V; Rocca MA; Annovazzi P; Pulizzi A; Rodegher M; Martinelli Boneschi F; Scotti R; Falini A; Sormani MP; Comi G; Filippi M
    Neurology; 2009 Dec; 73(22):1842-8. PubMed ID: 19949030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.
    Traboulsee A; Simon JH; Stone L; Fisher E; Jones DE; Malhotra A; Newsome SD; Oh J; Reich DS; Richert N; Rammohan K; Khan O; Radue EW; Ford C; Halper J; Li D
    AJNR Am J Neuroradiol; 2016 Mar; 37(3):394-401. PubMed ID: 26564433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement.
    Vellinga MM; Oude Engberink RD; Seewann A; Pouwels PJ; Wattjes MP; van der Pol SM; Pering C; Polman CH; de Vries HE; Geurts JJ; Barkhof F
    Brain; 2008 Mar; 131(Pt 3):800-7. PubMed ID: 18245785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A preliminary study comparing the sensitivity of serial monthly enhanced MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in primary progressive multiple sclerosis.
    Filippi M; Rovaris M; Gasperini C; Capra R; Bastianello S; Kuhne I; Yousry TA
    J Neuroimaging; 1998 Apr; 8(2):88-93. PubMed ID: 9557146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between enhancing lesion number and volume on standard and triple dose gadolinium-enhanced brain MRI scans from patients with multiple sclerosis.
    Rovaris M; Bastianello S; Capra R; Comi G; Yousry TA; Filippi M
    Magn Reson Imaging; 1999 Sep; 17(7):985-8. PubMed ID: 10463648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
    Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of disease activity in multiple sclerosis phenotypes with combined gadolinium- and superparamagnetic iron oxide-enhanced MR imaging.
    Tourdias T; Roggerone S; Filippi M; Kanagaki M; Rovaris M; Miller DH; Petry KG; Brochet B; Pruvo JP; Radüe EW; Dousset V
    Radiology; 2012 Jul; 264(1):225-33. PubMed ID: 22723563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gadolinium-DTPA-enhanced MR imaging of spinal neoplasms: preliminary investigation and comparison with unenhanced spin-echo and STIR sequences.
    Stimac GK; Porter BA; Olson DO; Gerlach R; Genton M
    AJR Am J Roentgenol; 1988 Dec; 151(6):1185-92. PubMed ID: 3055895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI.
    Cercignani M; Bozzali M; Iannucci G; Comi G; Filippi M
    J Neurol; 2002 Jul; 249(7):875-83. PubMed ID: 12140672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis.
    Thorpe JW; Kidd D; Moseley IF; Kenndall BE; Thompson AJ; MacManus DG; McDonald WI; Miller DH
    Neurology; 1996 Feb; 46(2):373-8. PubMed ID: 8614497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of chemical fat-saturation pulse added to T1-weighted spin-echo sequence in evaluating gadolinium-enhancing brain lesions in multiple sclerosis.
    Sardanelli F; Schiavoni S; Iozzelli A; Fausto A; Aliprandi A; Mancardi GL; Filippi M
    Radiol Med; 2007 Dec; 112(8):1244-51. PubMed ID: 18080095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Segmentation of gadolinium-enhanced lesions on MRI in multiple sclerosis.
    Datta S; Sajja BR; He R; Gupta RK; Wolinsky JS; Narayana PA
    J Magn Reson Imaging; 2007 May; 25(5):932-7. PubMed ID: 17457804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.
    Filippi M; Capra R; Campi A; Colombo B; Prandini F; Marcianò N; Gasparotti R; Comi G
    J Neurol Neurosurg Psychiatry; 1996 May; 60(5):526-30. PubMed ID: 8778257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.